NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Zhang, Jian ^a   Wu, Haidong ^a   Li, Pu ^a,b   Zhao, Yanzheng ^a   Liu, Min ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Central Hospital of Gynecology Obstetrics   (China)

Author keywords

Cervical cancer; miRNA; miRNA 130a; NF B; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 130A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN130 MICRORNA, HUMAN; PRIMER DNA;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION ASSAY; TRANSCRIPTION REGULATION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; HELA CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

BASE SEQUENCE; DNA PRIMERS; FEMALE; HELA CELLS; HUMANS; MICRORNAS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 84903963807     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-155     Document Type: Article

References (66)

1. Jo MJ, Lee JR, Cho IJ, Kim YW, Kim SC. Roots of erigeron annuus attenuate acute inflammation as mediated with the inhibition of NF- kappa B-associated nitric oxide and prostaglandin E2 production. Evid Based Complement Alternat Med 2013, 2013:297427.
2. Park SW, Cho C, Cho BN, Kim Y, Goo TW, Kim YI. 15-deoxy-delta12,14 -prostaglandin J 2 down-regulates activin-induced activin receptor, smad, and cytokines expression via suppression of NF- kappa B and MAPK signaling in HepG2 cells. PPAR Res 2013, 2013:751261.
3. Ling H, Gray CB, Zambon AC, Grimm M, Gu Y, Dalton N, Purcell NH, Peterson K, Brown JH. Ca2+/Calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res 2013, 112(6):935-944.
4. Zhang J, Chen J, Yang J, Xu CW, Pu P, Ding JW, Jiang H. Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway. Cell Physiol Biochem 2013, 31(2-3):230-241.
5. Hyldahl RD, Schwartz LM, Clarkson PM. NF-KB activity functions in primary pericytes in a cell- and non-cell-autonomous manner to affect myotube formation. Muscle Nerve 2013, 47(4):522-531.
6. Limpert AS, Bai S, Narayan M, Wu J, Yoon SO, Carter BD, Lu QR. NF-kappaB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci 2013, 33(6):2388-2397.
7. Ivanov VN, Ronai Z. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-kappaB activity and Fas expression. Oncogene 2000, 19(26):3003-3012.
8. Zhang W, Zhao S, Li Y, Peng G, Han P. Acute blood glucose fluctuation induces myocardial apoptosis through oxidative stress and nuclear factor-kB activation. Cardiology 2013, 124(1):11-17.
9. Sung B, Ahn KS, Aggarwal BB. Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res 2010, 70(8):3259-3268.
10. Jin HR, Jin SZ, Cai XF, Li D, Wu X, Nan JX, Lee JJ, Jin X. Cryptopleurine targets NF-kappaB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis. PLoS One 2012, 7(6):e40355.
11. Zhou R, Hu G, Gong AY, Chen XM. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 2010, 38(10):3222-3232.
12. Pfeffer LM. The role of nuclear factor kappaB in the interferon response. J Interferon Cytokine Res 2011, 31(7):553-559.
13. Konecny FA. Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis. J Res Med Sci 2010, 15(6):348-358.
14. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 2002, 35(1):28-40.
15. Kageyama A, Matsui H, Ohta M, Sambuichi K, Kawano H, Notsu T, Imada K, Yokoyama T, Kurabayashi M. Palmitic acid induces osteoblastic differentiation in vascular smooth muscle cells through ACSL3 and NF-kappaB, novel targets of eicosapentaenoic acid. PLoS One 2013, 8(6):e68197.
16. Liu S, Chen J, Cai X, Wu J, Chen X, Wu YT, Sun L, Chen ZJ. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2:e00785.
17. Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, Ghosh G, Stark GR, Lu T. PRMT5 dimethylates R30 of the p65 subunit to activate NF-kappaB. Proc Natl Acad Sci U S A 2013, 110(33):13516-13521.
18. Majetschak M, Obertacke U, Schade FU, Bardenheuer M, Voggenreiter G, Bloemeke B, Heesen M. Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients. Clin Diagn Lab Immunol 2002, 9(6):1205-1211.
19. Mittal R, Sharma S, Chhibber S, Harjai K. Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa. Can J Infect Dis Med Microbiol 2009, 20(3):e35-e42.
20. He X, Shu J, Xu L, Lu C, Lu A. Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-a and IL-1beta production in THP-1 cells. Molecules 2012, 17(3):3155-3164.
21. Merghani TH, Saeed A, Alawad A. Changes in plasma IL4, TNFa and CRP in response to regular passive smoking at home among healthy school children in Khartoum, Sudan. Afr Health Sci 2012, 12(1):41-47.
22. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3(9):745-756.
23. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992, 13(5):151-153.
24. Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie?. Cell 2004, 116(4):491-497.
25. Balkwill F, Joffroy C. TNF: a tumor-suppressing factor or a tumor-promoting factor?. Future Oncol 2010, 6(12):1833-1836.
26. Fajardo LF, Kwan HH, Kowalski J, Prionas SD, Allison AC. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 1992, 140(3):539-544.
27. Rube CE, Wilfert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rube C. Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol J Eur Soc Ther Radiol Oncol 2002, 64(2):177-187.
28. Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25(8):1543-1549.
29. Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 2005, 65(22):10355-10362.
30. Sorimachi K, Waring P, Hapel AJ, Fukasawa I, Kaneko Y, Masawa N. Characterisation of apoptosis in myb-transformed hematopoietic cell (MTHC-A) lines: TNF-alpha-induced apoptosis and prevention by cAMP. J Clin Exp Hematop 2013, 53(2):115-120.
31. Kim HR, Heo YM, Jeong KI, Kim YM, Jang HL, Lee KY, Yeo CY, Kim SH, Lee HK, Kim SR, Kim EG, Choi JK. FGF-2 inhibits TNF-alpha mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells. BMB Rep 2012, 45(5):287-292.
32. Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI. Studying micro RNA function and dysfunction in Alzheimer's disease. Front Genet 2012, 3:327.
33. Fabbri M. Targeting ncRNAs to combat metastases. Epigenomics 2010, 2(6):719-721.
34. Ryu I, Park JH, An S, Kwon OS, Jang SK. eIF4GI facilitates the MicroRNA-mediated gene silencing. PLoS One 2013, 8(2):e55725.
35. Zhdanov VP. Conditions of appreciable influence of microRNA on a large number of target mRNAs. Mol Biosyst 2009, 5(6):638-643.
36. Kim GH, Samant SA, Earley JU, Svensson EC. Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One 2009, 4(7):e6161.
37. Wu WH, Hu CP, Chen XP, Zhang WF, Li XW, Xiong XM, Li YJ. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens 2011, 24(10):1087-1093.
38. Hager M, Pedersen CC, Larsen MT, Andersen MK, Hother C, Gronbaek K, Jarmer H, Borregaard N, Cowland JB. MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-beta1 stimulation in granulocytic precursors. Blood 2011, 118(25):6649-6659.
39. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, Charles K, Klemm F, Pukrop T, Binder C, Balkwill FR. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 2005, 175(2):1197-1205.
40. Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G, Chiariello M, Croce CM. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2012, 31(5):634-642.
41. Kovaleva V, Mora R, Park YJ, Plass C, Chiramel AI, Bartenschlager R, Dohner H, Stilgenbauer S, Pscherer A, Lichter P, Seiffert M. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012, 72(7):1763-1772.
42. Wu K, Tian S, Zhou H, Wu Y. Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochem Pharmacol 2013, 85(12):1753-1760.
43. Kim JM, Cho HH, Lee SY, Hong CP, Yang J, Kim YS, Suh KT, Jung JS. Role of IRAK1 on TNF-induced proliferation and NF-kB activation in human bone marrow mesenchymal stem cells. Cell Physiol Biochem 2012, 30(1):49-60.
44. Mizumoto Y, Kyo S, Kiyono T, Takakura M, Nakamura M, Maida Y, Mori N, Bono Y, Sakurai H, Inoue M. Activation of NF-kappaB is a novel target of KRAS-induced endometrial carcinogenesis. Clin Cancer Res 2011, 17(6):1341-1350.
45. Takada Y, Khuri FR, Aggarwal BB. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis. J Biol Chem 2004, 279(25):26287-26299.
46. Zuo QP, Liu SK, Li ZJ, Li B, Zhou YL, Guo R, Huang LH. NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG(2) hepatoma cell line. Eur J Pharmacol 2011, 672(1-3):113-120.
47. Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Feng Z, Porter AG, Castle VP, Opipari AW. NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem 2001, 276(52):48921-48929.
48. Hettmann T, DiDonato J, Karin M, Leiden JM. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med 1999, 189(1):145-158.
49. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 2004, 13(6):853-865.
50. Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, Kaparakis-Liaskos M, Sarvestani ST, Yang YH, Xu D, Corr SC, Morand EF, Williams BR. A miR-19 regulon that controls NF-kappaB signaling. Nucleic Acids Res 2012, 40(16):8048-8058.
51. Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, Wu J, Hu B, Cheng SY, Li M, Li J. TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. J Clin Invest 2012, 122(10):3563-3578.
52. Dell'aversana C, Altucci L. miRNA-mediated deregulation in leukemia. Front Genet 2012, 3:252.
53. Anand S. A brief primer on microRNAs and their roles in angiogenesis. Vasc Cell 2013, 5(1):2.
54. Hou X, Tang Z, Liu H, Wang N, Ju H, Li K. Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs. PLoS One 2012, 7(12):e52123.
55. Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, Behrmann I, Kreis S. Interferon-gamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Commun Signal 2012, 10(1):41.
56. Jethwa K, Wei J, McEnery K, Heimberger AB. miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma. Clin Investig (Lond) 2011, 1(12):1637-1650.
57. Biyashev D, Qin G. E2F and microRNA regulation of angiogenesis. Am J Cardiovasc Dis 2011, 1(2):110-118.
58. Wang G, Wang X, Yu H, Wei S, Williams N, Holmes DL, Halfmann R, Naidoo J, Wang L, Li L, Chen S, Harran P, Lei X, Wang X. Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol 2013, 9(2):84-89.
59. Leahomschi S, Molinsky J, Klanova M, Andera L, Peterka M, Gasova Z, Klener P, Trneny M, Necas E, Simonova T, Zivny J, Klener P. Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL). Neoplasma 2013, 60(2):223-231.
60. Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci 2008, 13:5094-5107.
61. Rahman I, Gilmour PS, Jimenez LA, MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 2002, 234-235(1-2):239-248.
62. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007, 26(10):1385-1397.
63. Nickles D, Falschlehner C, Metzig M, Boutros M. A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling. Mol Cell Biol 2012, 32(17):3372-3381.
64. Old LJ. Tumor necrosis factor (TNF). Science 1985, 230(4726):630-632.
65. Shinobu N, Iwamura T, Yoneyama M, Yamaguchi K, Suhara W, Fukuhara Y, Amano F, Fujita T. Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett 2002, 517(1-3):251-256.
66. Suk K, Kim YH, Chang I, Kim JY, Choi YH, Lee KY, Lee MS. IFNalpha sensitizes ME-180 human cervical cancer cells to TNFalpha-induced apoptosis by inhibiting cytoprotective NF-kappaB activation. FEBS Lett 2001, 495(1-2):66-70.